Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 18;102(33):e34307.
doi: 10.1097/MD.0000000000034307.

Assessment of patellar cartilage cross-sectional area in patients with lower grade chondromalacia patella

Affiliations

Assessment of patellar cartilage cross-sectional area in patients with lower grade chondromalacia patella

Jaeho Cho et al. Medicine (Baltimore). .

Abstract

Chondromalacia patella (CMP) is abnormal softening of the cartilage of the underside the patella. It is a cause of anterior knee pain. Previous study has demonstrated that the patellar cartilage hypertrophy is correlated with early signs of CMP (Grade 1 or 2). However, no studies have investigated the clinical cutoff value of patella cartilage hypertrophy. Thus, we devised the patellar cartilage cross-sectional area (PCCSA) as a new predictive parameter for diagnosing the CMP. The purpose of this research was to compare MR measured PCCSA between CMP patients and gender matched healthy controls. The PCCSA samples were collected from 50 patients with CMP, and from 50 healthy controls who underwent knee MRI with no evidence of CMP. The T2-weighted turbo spin echo transverse MRI images were acquired. We measured the PCCSA on MRI using a PACS system. The PCCSA was measured on the axial angled sections through the whole images by drawing outlines. The average PCCSA was 104.28 ± 23.28 mm2 in the healthy controls and 134.09 ± 26.55 mm2 in the CMP group. CMP patients had significantly higher PCCSA (P < .001). Regarding the validity of PCCSA as predictors of CMP, Receiver Operating Characteristic curve analysis showed that the best cutoff point for the PCCSA was 116.24 mm2, with 72.0% sensitivity, 72.0% specificity, and the area under curve (AUC) of 0.79 (0.71-0.88). The PCCSA is a sensitive measurement parameter to predict low grade CMP. Thus, to evaluate CMP patients, the treating physician carefully inspect the PCCSA.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
Measurement of the PCCSA in a chondromalacia patella patient on T2-weighted transverse turbo spin echo fat-suppressed image. PCCSA = patellar cartilage cross-sectional area.
Figure 2.
Figure 2.
ROC curve of PCCSA for prediction of chondromalacia. The best cut off point of PCCSA was 116.24 mm2, with sensitivity of 72.0%, specificity of 72.0% and AUC of 0.79. PCCSA AUC (95% CI) = 0.79 (0.71–0.88). AUC = area under the curve, PCCSA = patellar cartilage cross-sectional area, ROC = receiver operating characteristic.

Similar articles

References

    1. Duran S, Cavusoglu M, Kocadal O, et al. . Association between trochlear morphology and chondromalacia patella: an MRI study. Clin Imaging. 2017;41:7–10. - PubMed
    1. Kim HJ, Lee SH, Kang CH, et al. . Evaluation of the chondromalacia patella using a microscopy coil: comparison of the two-dimensional fast spin echo techniques and the three-dimensional fast field echo techniques. Korean J Radiol. 2011;12:78–88. - PMC - PubMed
    1. Tuna BK, Semiz-Oysu A, Pekar B, et al. . The association of patellofemoral joint morphology with chondromalacia patella: a quantitative MRI analysis. Clin Imaging. 2014;38:495–8. - PubMed
    1. Zha GC, Feng S, Chen XY, et al. . Does the grading of chondromalacia patellae influence anterior knee pain following total knee arthroplasty without patellar resurfacing? Int Orthop. 2018;42:513–8. - PubMed
    1. Zhang S, Jia M, Luo Y, et al. . [Hyaluronate acid for treatment of chondromalacia patellae: a 52-week follow-up study]. Nan Fang Yi Ke Da Xue Xue Bao. 2019;39:791–6. - PMC - PubMed